113 related articles for article (PubMed ID: 32450094)
1. Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects.
Watanabe H; Miyahisa M; Chikamatsu M; Nishida K; Minayoshi Y; Takano M; Ichimizu S; Kobashigawa Y; Morioka H; Maeda H; Maruyama T
J Control Release; 2020 Aug; 324():522-531. PubMed ID: 32450094
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of long-acting FGF21 with controlled site-specific modification on nonalcoholic steatohepatitis.
Qi J; Guo Z; Zhu S; Jiang X; Wu Y; Chen Y; Hu F; Xiong J; Wu Y; Ye X; Liang X
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129797. PubMed ID: 38290625
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with pioglitazone and FGF21 mRNA synergistically ameliorates metabolic disorders in NAFLD rats.
Huang X; Xia Z; Huang Y; Sun Y; Zhang L; Xiong W; Zhang Z
Heliyon; 2023 Apr; 9(4):e15146. PubMed ID: 37123911
[TBL] [Abstract][Full Text] [Related]
5. Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.
Xu P; Ye X; Zhang Y; Yuan Q; Liu M; Wu Q; Ren G; Li D
J Diabetes Complications; 2015; 29(1):5-12. PubMed ID: 25456819
[TBL] [Abstract][Full Text] [Related]
6. Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes.
Hecht R; Li YS; Sun J; Belouski E; Hall M; Hager T; Yie J; Wang W; Winters D; Smith S; Spahr C; Tam LT; Shen Z; Stanislaus S; Chinookoswong N; Lau Y; Sickmier A; Michaels ML; Boone T; Véniant MM; Xu J
PLoS One; 2012; 7(11):e49345. PubMed ID: 23209571
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
8. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
9. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function.
Kim JH; Bae KH; Choi YK; Go Y; Choe M; Jeon YH; Lee HW; Koo SH; Perfield JW; Harris RA; Lee IK; Park KG
Diabetes Obes Metab; 2015 Feb; 17(2):161-9. PubMed ID: 25359298
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane G protein-coupled receptor 5 signaling stimulates fibroblast growth factor 21 expression concomitant with up-regulation of the transcription factor nuclear receptor Nr4a1.
Kiyama G; Nakashima KI; Shimada K; Murono N; Kakihana W; Imai H; Inoue M; Hirai T
Biomed Pharmacother; 2021 Oct; 142():112078. PubMed ID: 34449315
[TBL] [Abstract][Full Text] [Related]
12. A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.
Stanislaus S; Hecht R; Yie J; Hager T; Hall M; Spahr C; Wang W; Weiszmann J; Li Y; Deng L; Winters D; Smith S; Zhou L; Li Y; Véniant MM; Xu J
Endocrinology; 2017 May; 158(5):1314-1327. PubMed ID: 28324011
[TBL] [Abstract][Full Text] [Related]
13. Design of a Dual Agonist of Exendin-4 and FGF21 as a Potential Treatment for Type 2 Diabetes Mellitus and Obesity.
Zhang C; Gao G; Li Y; Ying J; Li J; Hu S
Iran J Pharm Res; 2023; 22(1):e131015. PubMed ID: 38116563
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Andersen B; Omar BA; Rakipovski G; Raun K; Ahrén B
Eur J Pharmacol; 2015 Oct; 764():189-194. PubMed ID: 26144370
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway.
Ying L; Li N; He Z; Zeng X; Nan Y; Chen J; Miao P; Ying Y; Lin W; Zhao X; Lu L; Chen M; Cen W; Guo T; Li X; Huang Z; Wang Y
Cell Death Dis; 2019 Sep; 10(9):665. PubMed ID: 31511499
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.
Yan X; Chen J; Zhang C; Zeng J; Zhou S; Zhang Z; Lu X; Chen J; Feng W; Li X; Tan Y
Cardiovasc Diabetol; 2015 Jun; 14(1):77. PubMed ID: 27391008
[TBL] [Abstract][Full Text] [Related]
18. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
20. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
